Related Experiment Videos
p53 point mutations in primary human gastric carcinomas
H Yokozaki1, H Kuniyasu, Y Kitadai
1Department of Pathology, Hiroshima University School of Medicine, Japan.
Journal of Cancer Research and Clinical Oncology
|January 1, 1992
Summary
p53 gene mutations are common in gastric cancer, even in early stages. Analysis revealed specific mutation patterns, suggesting their role in cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gastric carcinoma is a significant global health concern.
- The tumor suppressor gene p53 plays a critical role in preventing cancer.
- Understanding p53 mutations in gastric cancer is crucial for diagnosis and treatment.
Purpose of the Study:
- To analyze p53 point mutations in primary gastric carcinomas.
- To characterize the mutation spectrum of the p53 gene in gastric tumors.
- To investigate the occurrence of p53 mutations in early-stage gastric cancer.
Main Methods:
- cDNA deoxynucleotide sequencing was employed to analyze the p53 gene.
- Primary gastric carcinoma tissues were collected for mutation analysis.
- Mutations were identified within the open-reading frame and conserved domains of p53.
Main Results:
- p53 point mutations were detected in 9 out of 16 (56.3%) primary gastric carcinoma cases.
- Four of these cases exhibited mutations within highly conserved p53 domains.
- The mutation spectrum included frequent alterations at A:T pairs (50%) and a high incidence of transversions (29%).
Conclusions:
- p53 gene mutation is a frequent event in gastric carcinoma.
- These mutations occur early in the progression of gastric cancer.
- The specific p53 mutation spectrum provides insights into gastric carcinogenesis.